Head to head

Harmony XL vs Xeo (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview

Purchase cost: The catalog lists $80k–$120k for Xeo. No new-price range is on file for Harmony XL. Check the source notes and request current quotes.
Technology: Harmony XL: Nd:YAG. Xeo: IPL.
Practice fit: Both are listed under multi-app platform. Check each model’s US regulatory status and labeled indications for your intended use.

Device A

Multi-app platform

View full device profile →

Device B

Multi-app platform

View full device profile →

Price comparison

Price comparison: Alma Harmony XL vs Cutera Xeo
Attribute	Alma Harmony XL	Cutera Xeo
New price range	Not published	$80k–$120kSource not documented
Used asking range	$10,500–$29,950Reported source: Used listing · Aug 30, 2026	$18k–$40kSource not documented
Payback calculator	View ROI calculator	View ROI calculator
Next step	Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models. Browse current models

New price range

Alma Harmony XL: Not published
Cutera Xeo: $80k–$120kSource not documented

Used asking range

Alma Harmony XL: $10,500–$29,950Reported source: Used listing · Aug 30, 2026
Cutera Xeo: $18k–$40kSource not documented

Payback calculator

Alma Harmony XL: View ROI calculator
Cutera Xeo: View ROI calculator

Next step

Alma Harmony XL

Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models.

Browse current models

Cutera Xeo

Consumable economics

Consumable economics: Alma Harmony XL vs Cutera Xeo
Attribute	Alma Harmony XL	Cutera Xeo
Consumable cost / lock-in	—	Supply pricing is not documented with a dated source yet. Request an itemized supply quote.
Service cost	Not published	Not published

Consumable cost / lock-in

Alma Harmony XL: —
Cutera Xeo: Supply pricing is not documented with a dated source yet. Request an itemized supply quote.

Service cost

Alma Harmony XL: Not published
Cutera Xeo: Not published

FDA clearance

FDA clearance: Alma Harmony XL vs Cutera Xeo
Attribute	Alma Harmony XL	Cutera Xeo
FDA status & indication	FDA ClearedK072564 Read FDA indication wording “[…] 540-950 nm VL/PL, VP, and SSR Module AFT Handpieces: The Advanced Fluorescence Technology (AFT) 540-950 nm VL/PL, VP, and SSR Module handpieces (with and without contact-cooling) are indicated for: The treatment of moderate inflammatory acne vulgaris. The treatment of benign pigmented epidermal lesions including dyschromia, hyperpigmentation, melasma, and ephelides (freckles), lentigines, nevi, melasma, and café-au-lait macules. The treatment of cutaneous lesions including warts, scars and striae. The treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations. The removal of unwanted hair to effect stable long-term or permanent hair reduction. Use on all skin types (Fitzpatrick I-VI). 570-950 nm SR Module AFT Handpiece: The Advanced Fluorescence Technology (AFT) 570-950 nm SR Module handpiece (with and without contact-cooling) is indicated for: The treatment of moderate inflammatory acne vulgaris. The treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma and ephelides (freckles). The treatment of face and body vascular and pigmented lesions. The treatment of cutaneous lesions, including scars and striae. The treatment of benign cutaneous vascular lesions, including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, melasma, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations. The removal of unwanted hair to effect stable long-term or permanent hair reduction. Use on all skin types (Fitzpatrick I-VI).”	FDA ClearedK233237 Read FDA indication wording “IPL Hair Removal Device is indicated for the removal of unwanted hair. The IPL Hair Removal Device is also indicated for the permanent reduction in hair regrowth, defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9 and 12 months after the completion of a treatment regime.”

FDA status & indication

Alma Harmony XL: FDA ClearedK072564
Read FDA indication wording
“[…] 540-950 nm VL/PL, VP, and SSR Module AFT Handpieces: The Advanced Fluorescence Technology (AFT) 540-950 nm VL/PL, VP, and SSR Module handpieces (with and without contact-cooling) are indicated for: The treatment of moderate inflammatory acne vulgaris. The treatment of benign pigmented epidermal lesions including dyschromia, hyperpigmentation, melasma, and ephelides (freckles), lentigines, nevi, melasma, and café-au-lait macules. The treatment of cutaneous lesions including warts, scars and striae. The treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations. The removal of unwanted hair to effect stable long-term or permanent hair reduction. Use on all skin types (Fitzpatrick I-VI). 570-950 nm SR Module AFT Handpiece: The Advanced Fluorescence Technology (AFT) 570-950 nm SR Module handpiece (with and without contact-cooling) is indicated for: The treatment of moderate inflammatory acne vulgaris. The treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma and ephelides (freckles). The treatment of face and body vascular and pigmented lesions. The treatment of cutaneous lesions, including scars and striae. The treatment of benign cutaneous vascular lesions, including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, melasma, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations. The removal of unwanted hair to effect stable long-term or permanent hair reduction. Use on all skin types (Fitzpatrick I-VI).”
Cutera Xeo: FDA ClearedK233237
Read FDA indication wording
“IPL Hair Removal Device is indicated for the removal of unwanted hair. The IPL Hair Removal Device is also indicated for the permanent reduction in hair regrowth, defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9 and 12 months after the completion of a treatment regime.”

Which chains run each

Which chains run each: Alma Harmony XL vs Cutera Xeo
Attribute	Alma Harmony XL	Cutera Xeo
Chain adoption	1 recorded pairing	0 recorded pairings
Chains using it	LaserAway(Confirmed)	—
Approved reviews	0	0

Chain adoption

Alma Harmony XL: 1 recorded pairing
Cutera Xeo: 0 recorded pairings

Chains using it

Alma Harmony XL: LaserAway(Confirmed)
Cutera Xeo: —

Approved reviews

Alma Harmony XL: 0
Cutera Xeo: 0

Specs and platform

Specs and platform: Alma Harmony XL vs Cutera Xeo
Attribute	Alma Harmony XL	Cutera Xeo
Manufacturer	Alma	Cutera
Built by (OEM)	Alma Lasers Ltd.	Cutera Inc.
Category	Multi-app platform	Multi-app platform
Technology	AFT pulsed light + Nd:YAG + more (Nd:YAG)	Platform: CoolGlide YAG + LimeLight IPL + ProWave 770 (IPL)
Launch year	2010	2003
Status	Discontinued	Current
Manufacturer source record	No linked source on file.	No linked source on file.

Manufacturer

Alma Harmony XL: Alma
Cutera Xeo: Cutera

Built by (OEM)

Alma Harmony XL: Alma Lasers Ltd.
Cutera Xeo: Cutera Inc.

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

Alma Harmony XL Pro

Multi-app platform

New: $60k–$110k

Sciton Joule / Joule X

Multi-app platform

New: $100k–$200k

Sciton mJoule

Multi-app platform

New: $110k–$150k

Rohrer Aesthetics Spectrum

Multi-app platform

New: $79,995 (Rohrer-advertised price)

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.